Ahn-gook Pharmaceutical KRX:001540KOSDAQ
안국약품 · Korean news coverage and regulatory filings, organized.
Articles, 24h2
Articles, 7 days5
DART filings, 7 days1
Articles tracked5since Sep 11
In Q2 2026, Ahn-gook Pharmaceutical reported revenue of ₩91.9bn, up 19.6% year on year, and operating profit of ₩8.6bn. Ahn-gook Pharmaceutical (안국약품) appeared in 5 Korean news articles and 1 DART filing over the past seven days. Coverage peaked on Sep 14 with 5 articles. The most common catalyst was tech & capacity (2).
Ahn-gook Pharmaceutical quarterly results consolidated, KRW
| Quarter | Revenue | YoY | Operating profit | Net income |
|---|---|---|---|---|
| Q2 2026 | ₩91.9bn | +19.6% | ₩8.6bn | ₩8.6bn |
| Q1 2026 | ₩98.9bn | +30.6% | ₩16.0bn | ₩12.4bn |
| Q4 2025 derived | ₩76.6bn | +8.4% | −₩5.9bn | −₩2.6bn |
| Q3 2025 | ₩77.7bn | +15.1% | ₩4.9bn | ₩3.4bn |
| Q2 2025 | ₩76.8bn | +14.4% | ₩5.0bn | ₩3.1bn |
| Q1 2025 | ₩75.8bn | +15.2% | ₩5.9bn | ₩3.5bn |
| Q4 2024 derived | ₩70.7bn | +10.1% | ₩1.2bn | −₩657m |
| Q3 2024 | ₩67.5bn | +22.0% | ₩708m | −₩372m |
Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases.
Ahn-gook Pharmaceutical top stories 2 weeks, by number of outlets
- 1
- 2
- 3
- 4
Latest Ahn-gook Pharmaceutical news Korean headlines
-
안국약품, ‘액제’ 전용공장 신축 공사 기공식 개최…내년 10월 준공 목표
1 more on this story · 1 outlets
- 안국약품, 액제 전용공장 2027년 10월 목표 기공식 개최약사공론 · Sep 14 15:59

